Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis

Podobne zapisy

• Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
  od: Suzuki, Takako, i wsp.
  Wydane: (2018)
• Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment
  od: Nakamura, Yukio, i wsp.
  Wydane: (2017)
• Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
  od: Suzuki, Takako, i wsp.
  Wydane: (2017)
• Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
  od: Suzuki, Takako, i wsp.
  Wydane: (2018)
• Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients
  od: Suzuki, Takako, i wsp.
  Wydane: (2018)